AnalystUniversity of North Carolina at Chapel HillChapel Hill, United States
Disclosure information not submitted.
Investigating the association between Incretin-based therapies and thyroid cancer incidence using United States Medicare data 2007-2019
Tuesday, August 27, 20249:15 AM – 9:30 AM CEST
A Novel High Dimensional Approach to Assess Treatment Heterogeneity in Claims Data: Sodium-glucose Cotransporter-2 inhibitors (SGLT2i) vs Glucagon-like Peptide-1 Receptor Agonists (GLP1RA) on Hospitalized Heart Failure Risk
Wednesday, August 28, 20248:45 AM – 9:00 AM CEST
Using High Dimensional Iterative Causal Forest (hdiCF) to Identify Subgroups with Heterogeneous Treatment Effects: Glucagon-like Peptide 1 Receptor Agonists (GLP1RA) vs Sulfonylurea (SU) on Asthma Exacerbations
Wednesday, August 28, 20242:00 PM – 2:15 PM CEST
